Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.8493
-0.0908 (-9.66%)
At close: Oct 29, 2026, 4:00 PM EDT
0.8301
-0.0192 (-2.26%)
Pre-market: Oct 30, 2026, 7:35 AM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $27.56 million as of October 29, 2026. It is the 34,463rd most valuable company in the world and the 5,010th biggest in the United States. Its market cap has decreased by 48.37% in one year.
Market Cap
27.56M
Enterprise Value
96.81M
1-Year Change
-48.37%
Global Rank
Country Rank
#5,010 United States
Category
ChartMarket Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $27.56M, a decrease of -92.17%. That is a compound annual growth rate of -29.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 27.56M | -12.82% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 33.05M |
| EyePoint | 32.54M |
| Aligos Therapeutics | 32.28M |
| Filana Therapeutics | 31.43M |
| Metagenomi Therapeutics | 31.04M |
| BriaCell Therapeutics | 30.12M |
| TransCode Therapeutics | 29.46M |
| NextCure | 29.02M |